With more than four decades of clinical research much is known about the natural history of T1D before and after clinical diagnosis. Autoimmunity occurs early in life, that islet autoimmunity inevitably leads to clinically overt disease, and that some immune therapies can alter the disease course.

This exclusive KOL Interview shares insights on disease-modifying therapies in T1DM.